Coherus Oncology, Inc. (CHRS)
NASDAQ: CHRS · Real-Time Price · USD
1.200
-0.030 (-2.44%)
At close: Dec 5, 2025, 4:00 PM EST
1.210
+0.010 (0.83%)
After-hours: Dec 5, 2025, 5:01 PM EST
Coherus Oncology Employees
Coherus Oncology had 228 employees as of December 31, 2024. The number of employees decreased by 78 or -25.49% compared to the previous year.
Employees
228
Change (1Y)
-78
Growth (1Y)
-25.49%
Revenue / Employee
$1,218,105
Profits / Employee
$679,697
Market Cap
145.05M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
CHRS News
- 25 days ago - Coherus Oncology, Inc. (CHRS) Presents at UBS Global Healthcare Conference 2025 Transcript - Seeking Alpha
- 4 weeks ago - Coherus Oncology, Inc. (CHRS) Q3 2025 Earnings Call Transcript - Seeking Alpha
- 4 weeks ago - Coherus Oncology Presents at SITC Clinical Multiomic Biomarker Data for CHS-114, a Highly Selective anti-CCR8 Cytolytic Antibody - GlobeNewsWire
- 4 weeks ago - Coherus Oncology Reports Third Quarter 2025 Financial Results and Provides Business Update - GlobeNewsWire
- 4 weeks ago - Arvind Sood joins Coherus Oncology as Chief Strategy and Corporate Affairs Officer - GlobeNewsWire
- 5 weeks ago - Coherus Oncology to Report Third Quarter 2025 Financial Results on November 6, 2025 - GlobeNewsWire
- 6 weeks ago - Coherus Oncology to Participate in Upcoming Investor Conferences - GlobeNewsWire
- 2 months ago - 4 Biotechnology Stocks Lead Momentum Gains Amid Strong Technicals - Benzinga